Filing Details
- Accession Number:
- 0000899243-17-015285
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-05 16:05:42
- Reporting Period:
- 2017-06-01
- Filing Date:
- 2017-06-05
- Accepted Time:
- 2017-06-05 16:05:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1512762 | Coherus Biosciences Inc. | CHRS | Biological Products, (No Disgnostic Substances) (2836) | 273615821 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1622080 | C. Alan Herman | Coherus Biosciences, Inc. 333 Twin Dolphin Drive, Suite 600 Redwood City CA 94065 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.0001 Par Value | Disposition | 2017-06-01 | 9,601 | $20.20 | 69,518 | No | 4 | S | Direct | |
Common Stock, $0.0001 Par Value | Disposition | 2017-06-01 | 1,732 | $20.98 | 67,786 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.0001 Par Value | 300,164 | Indirect | By Trust |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
- The transaction was executed in multiple trades in prices ranging from $19.85 to $20.85, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- The transaction was executed in multiple trades in prices ranging from $20.90 to $21.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- These shares are held by the Herman Trust, dated March 16, 2001, of which Reporting Person is a co trustee.